{"title_page": "AM-906", "text_new": "{{Drugbox\n| verifiedrevid = 456506376\n| IUPAC_name = (6a''R'',9''R'',10a''R'')-3-[(''Z'')-hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[''c'']chromen-1-ol\n| image = AM-906.svg\n| width = 240\n\n<!--Clinical data-->\n| tradename =  \n| legal_status =  \n| routes_of_administration =  \n\n<!--Pharmacokinetic data-->\n| metabolism =  \n| elimination_half-life =\n| excretion =  \n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 180989-26-8\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = EW1UQ3B1Y8\n| ChEMBL_Ref = {{ebicite|correct|EBI}}\n| ChEMBL = 127848\n| PubChem = 10089808\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 8174103\n\n<!--Chemical data-->\n| C=23 | H=34 | O=3 \n| molecular_weight = 358.513 g/mol\n| smiles = CCCCC/C=C\\C1=CC2=C(C3CC(CCC3C(O2)(C)C)CO)C(=C1)O\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C23H34O3/c1-4-5-6-7-8-9-16-13-20(25)22-18-12-17(15-24)10-11-19(18)23(2,3)26-21(22)14-16/h8-9,13-14,17-19,24-25H,4-7,10-12,15H2,1-3H3/b9-8-/t17-,18-,19-/m1/s1\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = NJIKRWBGUIYKJM-FORFBYLSSA-N\n}}\n\n'''AM-906''' (part of the [[List of AM cannabinoids|AM cannabinoid series]]) is an [[analgesic]] drug which is a [[cannabinoid]] [[agonist]]. It is conformationally restricted by virtue of the double bond on its side chain, leading an increased affinity for and selectivity between [[Cannabinoid receptor 1|CB<sub>1</sub>]] and [[Cannabinoid receptor 2|CB<sub>2</sub>]] receptors.<ref name=\"Busch-PetersenHill1996\">{{cite journal | vauthors = Busch-Petersen J, Hill WA, Fan P, Khanolkar A, Xie XQ, Tius MA, Makriyannis A | title = Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs | journal = Journal of Medicinal Chemistry | volume = 39 | issue = 19 | pages = 3790\u20136 | date = September 1996 | pmid = 8809166 | doi = 10.1021/jm950934b | authorlink7 = Alexandros Makriyannis }}</ref> It is a potent and selective agonist for the  CB<sub>1</sub> cannabinoid [[Receptor (biochemistry)|receptor]], with a [[Dissociation constant|''K''<sub>i</sub>]] of 0.8&nbsp;nM at CB<sub>1</sub> and 9.5&nbsp;nM at CB<sub>2</sub>, a selectivity of almost 12x.<ref>{{cite journal | vauthors = Papahatjis DP, Kourouli T, Abadji V, Goutopoulos A, Makriyannis A | title = Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols | journal = Journal of Medicinal Chemistry | volume = 41 | issue = 7 | pages = 1195\u2013200 | date = March 1998 | pmid = 9544219 | doi = 10.1021/jm970277i }}</ref>\n\nThe corresponding ''E'' or [[trans isomer]] is [[AM-905]].\n\n== See also ==\n* [[AM-1235]]\n* [[AM-2389]]\n\n== References ==\n{{reflist}}\n\n{{cannabinoids}}\n\n[[Category:Benzochromenes]]\n[[Category:Primary alcohols]]\n[[Category:Phenols]]\n[[Category:AM cannabinoids]]\n\n{{cannabinoid-stub}}\n", "text_old": "{{Drugbox\n| verifiedrevid = 456506376\n| IUPAC_name = (6a''R'',9''R'',10a''R'')-3-[(''Z'')-hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[''c'']chromen-1-ol\n| image = AM-906.svg\n| width = 240\n\n<!--Clinical data-->\n| tradename =  \n| legal_status =  \n| routes_of_administration =  \n\n<!--Pharmacokinetic data-->\n| metabolism =  \n| elimination_half-life =\n| excretion =  \n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 180989-26-8\n| ChEMBL_Ref = {{ebicite|correct|EBI}}\n| ChEMBL = 127848\n| PubChem = 10089808\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 8174103\n\n<!--Chemical data-->\n| C=23 | H=34 | O=3 \n| molecular_weight = 358.513 g/mol\n| smiles = CCCCC/C=C\\C1=CC2=C(C3CC(CCC3C(O2)(C)C)CO)C(=C1)O\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C23H34O3/c1-4-5-6-7-8-9-16-13-20(25)22-18-12-17(15-24)10-11-19(18)23(2,3)26-21(22)14-16/h8-9,13-14,17-19,24-25H,4-7,10-12,15H2,1-3H3/b9-8-/t17-,18-,19-/m1/s1\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = NJIKRWBGUIYKJM-FORFBYLSSA-N\n}}\n\n'''AM-906''' (part of the [[List of AM cannabinoids|AM cannabinoid series]]) is an [[analgesic]] drug which is a [[cannabinoid]] [[agonist]]. It is conformationally restricted by virtue of the double bond on its side chain, leading an increased affinity for and selectivity between [[Cannabinoid receptor 1|CB<sub>1</sub>]] and [[Cannabinoid receptor 2|CB<sub>2</sub>]] receptors.<ref name=\"Busch-PetersenHill1996\">{{cite journal | vauthors = Busch-Petersen J, Hill WA, Fan P, Khanolkar A, Xie XQ, Tius MA, Makriyannis A | title = Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs | journal = Journal of Medicinal Chemistry | volume = 39 | issue = 19 | pages = 3790\u20136 | date = September 1996 | pmid = 8809166 | doi = 10.1021/jm950934b | authorlink7 = Alexandros Makriyannis }}</ref> It is a potent and selective agonist for the  CB<sub>1</sub> cannabinoid [[Receptor (biochemistry)|receptor]], with a [[Dissociation constant|''K''<sub>i</sub>]] of 0.8&nbsp;nM at CB<sub>1</sub> and 9.5&nbsp;nM at CB<sub>2</sub>, a selectivity of almost 12x.<ref>{{cite journal | vauthors = Papahatjis DP, Kourouli T, Abadji V, Goutopoulos A, Makriyannis A | title = Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols | journal = Journal of Medicinal Chemistry | volume = 41 | issue = 7 | pages = 1195\u2013200 | date = March 1998 | pmid = 9544219 | doi = 10.1021/jm970277i }}</ref>\n\nThe corresponding ''E'' or [[trans isomer]] is [[AM-905]].\n\n== See also ==\n* [[AM-1235]]\n* [[AM-2389]]\n\n== References ==\n{{reflist}}\n\n{{cannabinoids}}\n\n[[Category:Benzochromenes]]\n[[Category:Primary alcohols]]\n[[Category:Phenols]]\n[[Category:AM cannabinoids]]\n\n{{cannabinoid-stub}}\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/AM-906"}
